SQZ Biotech to Present at Investor Conferences in First Quarter 2018

Monday, February 5, 2018 Research News
Email Print This Page Comment bookmark
Font : A-A+

WATERTOWN, Mass., Feb. 5, 2018 /PRNewswire/ -- SQZ Biotech (SQZ), a preclinical stage biotechnology company developing cell

therapies based on its proprietary CellSqueeze® technology, announced today that management will be presenting at three investor conferences in the first quarter of 2018.

BIO CEO and Investor Conference in New York, NY

February 12 - February 13, 2018 Presentation Time: February 12, 2018 at 10:30am

Cowen and Company Annual Healthcare Conference in Boston, MA March 12March 14, 2018 Presentation Time: March 12, 2018 at 2:30pm

Oppenheimer Annual Healthcare Conference in New York, NY March 20March 21, 2018 Presentation Time: March 21, 2018 at 8:35am

"We are thrilled to have the opportunity to present SQZ's vision of developing a new generation of cell-based therapies," remarked Armon Sharei, PhD, CEO at SQZ. "It is an honor to be selected as a private company and we look forward to discussing our potential to implement previously inaccessible therapies across multiple disease areas."

About SQZ Biotech SQZ Biotechnologies is a Massachusetts-based, privately held company developing cellular therapies for multiple indications using the proprietary CellSqueeze® technology. Through internal research programs and external partnerships, SQZ's unique cell engineering capabilities are being used to develop a new generation of cell therapies to address a wide range of clinical challenges. For more information please visit www.sqzbiotech.com.

SQZ Contact: Rebecca Cohen Manager, Corporate Relations & Administration rebecca.cohen@sqzbiotech.com 617-758-8672 ext. 728

SQZ Media Contact: Justin Jackson Burns McClellan  212-213-0006, ext. 327  jjackson@burnsmc.com

Cision View original content:http://www.prnewswire.com/news-releases/sqz-biotech-to-present-at-investor-conferences-in-first-quarter-2018-300593144.html

SOURCE SQZ Biotechnologies

Advertisement


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store